Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test
September 19, 2021 14:58 ET
|
Sorrento Therapeutics, Inc.
As a general screening for all-comers (i.e. COVID-19 symptomatic and asymptomatic populations), COVISTIX (n=783) has an 81% sensitivity vs. 62% (n=2202) sensitivity by globally leading Panbio rapid...
FDA Advisory Committee Votes Unanimously in Favor of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-Risk Populations
September 18, 2021 03:40 ET
|
BioNTech SE
Committee reviewed clinical data showing a booster dose of COMIRNATY® elicits high neutralization titers against SARS-CoV-2 and all currently tested variants Reactogenicity profile within seven days...
FDA-Beratungsausschuss unterstützt einstimmig Notfallzulassung für COMIRNATY®-Auffrischungsimpfung bei Personen ab 65 Jahren und bestimmten Risikogruppen
September 18, 2021 03:40 ET
|
BioNTech SE
Der FDA-Beratungsausschuss prüfte klinische Daten zu einer Auffrischungsimpfung mit COMIRNATY®, die hohe neutralisierende Antikörpertiter gegen SARS-CoV-2 und alle bisher untersuchten Varianten...
ATIF Holdings Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 17, 2021 22:02 ET
|
ATIF Holdings Limited
LOS ANGELES, Sept. 17, 2021 (GLOBE NEWSWIRE) -- ATIF Holdings Limited (Nasdaq: ATIF, the “Company”), a holding group providing business and financial consulting in Asia and North America, today...
Repurchase of shares in Millicom
September 17, 2021 17:00 ET
|
Millicom International Cellular S.A.
Repurchase of shares in Millicom Luxembourg, September 17, 2021 - During the period September 9, 2021 – September 15, 2021, Millicom repurchased a total of 131,559 of its Swedish Depository...
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 17, 2021 16:52 ET
|
Ocugen
MALVERN, Pa., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness...
Organovo Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum
September 17, 2021 16:10 ET
|
Organovo, Inc.
SOLANA BEACH, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today announced that the Company’s annual meeting of shareholders, on September 14, 2021, at 9:00...
Pasithea Therapeutics Corp. Announces Closing of $24.0 Million Initial Public Offering
September 17, 2021 16:05 ET
|
Pasithea
MIAMI BEACH, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the research and discovery of new...
Grindrod Shipping Holdings Ltd. Announces Closing of IVS Bulk Financing and IVS Phoenix Acquisition
September 17, 2021 16:05 ET
|
Grindrod Shipping Holdings Ltd.
SINGAPORE, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or "Company" or “it” or “we”), a global provider of maritime...
Protara Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
September 17, 2021 16:05 ET
|
Protara Therapeutics
NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases...